[
  {
    "ts": "2026-02-27T04:53:17+00:00",
    "headline": "What Does the Street Think About Boston Scientific Corporation (BSX)?",
    "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best strong buy healthcare stocks to invest in. Boston Scientific Corporation (NYSE:BSX) announced on February 23 the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026. The company also received several rating updates following its fiscal Q4 and full-year earnings […]",
    "url": "https://finance.yahoo.com/news/does-street-think-boston-scientific-045317494.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c54b4a04-f4aa-3685-b257-fa29a1c9a040",
      "content": {
        "id": "c54b4a04-f4aa-3685-b257-fa29a1c9a040",
        "contentType": "STORY",
        "title": "What Does the Street Think About Boston Scientific Corporation (BSX)?",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE:BSX) is one of the best strong buy healthcare stocks to invest in. Boston Scientific Corporation (NYSE:BSX) announced on February 23 the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026. The company also received several rating updates following its fiscal Q4 and full-year earnings […]",
        "pubDate": "2026-02-27T04:53:17Z",
        "displayTime": "2026-02-27T04:53:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/45f2400d2f7f0dd44fd960cafcbec175",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Was Jim Cramer Right About Boston Scientific Corporation (BSX)?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pPbu5IVWFLzFUIu5nzLVlg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/45f2400d2f7f0dd44fd960cafcbec175.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAxutOZAcJj.3HgLdpxDDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/45f2400d2f7f0dd44fd960cafcbec175.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-street-think-boston-scientific-045317494.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-street-think-boston-scientific-045317494.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-27T18:09:23+00:00",
    "headline": "Boston Scientific Faces AXIOS Recall And US$11b Penumbra Deal Shift",
    "summary": "Boston Scientific (NYSE:BSX) announced a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems due to deployment complications linked to serious injuries and deaths. The company also arranged US$11b in new financing to support its pending acquisition of Penumbra. Boston Scientific operates as a major medical device company, with products used across gastrointestinal, cardiovascular, and other interventional procedures. A Class I recall is the most serious category...",
    "url": "https://finance.yahoo.com/news/boston-scientific-faces-axios-recall-180923019.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6a5c8179-c90e-3605-9f50-f8d53332742b",
      "content": {
        "id": "6a5c8179-c90e-3605-9f50-f8d53332742b",
        "contentType": "STORY",
        "title": "Boston Scientific Faces AXIOS Recall And US$11b Penumbra Deal Shift",
        "description": "",
        "summary": "Boston Scientific (NYSE:BSX) announced a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems due to deployment complications linked to serious injuries and deaths. The company also arranged US$11b in new financing to support its pending acquisition of Penumbra. Boston Scientific operates as a major medical device company, with products used across gastrointestinal, cardiovascular, and other interventional procedures. A Class I recall is the most serious category...",
        "pubDate": "2026-02-27T18:09:23Z",
        "displayTime": "2026-02-27T18:09:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-faces-axios-recall-180923019.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-faces-axios-recall-180923019.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]